A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular ASO activity
Malong, L.; Roskosch, J.; Hager, C.; Fortin, J.-P.; Schmucki, R.; Callow, M. G.; Weile, C.; Romeo, V.; Patsch, C.; Martin, S.; Costa, M.; Modrusan, Z.; Villasenor, R.; Koller, E.; Haley, B.; Spang, A.; Roudnicky, F.
Show abstract
Anti-sense oligonucleotides (ASOs) are modified synthetic single-stranded molecules with enhanced stability, activity, and bioavailability. They associate with RNA through sequence complementarity and can reduce or alter mRNA expression upon binding of splice site positions. To target RNA in the nucleus or cytoplasm, ASOs must cross membranes, a poorly understood process. We have performed an unbiased CRISPR/Cas9 knockout screen with a genetic splice reporter to identify genes that can increase or decrease ASOs activity, resulting in the most comprehensive catalog of ASOs-activity modifier genes. Distinct targets were uncovered, including AP1M1 and TBC1D23, linking ASOs activity to transport of cargo between the Golgi and endosomes. AP1M1 absence strongly increased ASO activity by delaying endosome-to-lysosome transport in vitro and in vivo. Prolonged ASOs residence time in the endosomal system may increase the likelihood of ASOs escape from this organelle before they reach lysosomes. This insight into AP1M1 role in ASOs trafficking suggests a way for enhancing the therapeutic efficacy of ASOs by manipulating the endolysosomal pathways.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbation. 97%
- Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM 97%
- Mapping PTBP splicing in human brain identifies targets for therapeutic splice switching including SYNGAP1 97%
Similar papers in this journal
- ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination deficient cells 97%
- Glucosylceramide induced ectosomes propagate pathogenic α-synuclein in Parkinson's disease 97%
- BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 96%
Similar papers in this journal
- SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species 96%
- Modular DNA Barcoding of Nanobodies Enables Multiplexed in situ Protein Imaging and High-throughput Biomolecule Detection 96%
- GFAT2 and AMDHD2 act in tandem to control the hexosamine biosynthetic pathway 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.